Navigation Links
CorVel Announces Record Earnings Per Share
Date:2/5/2008

14,026,000 13,813,000

Diluted 14,368,000 13,964,000

9 months ended 9 months ended

December 31, December 31,

2006 2007

Revenues 203,671,000 224,526,000

Cost of revenues 155,416,000 167,291,000

Gross profit 48,255,000 57,235,000

General and administrative 26,472,000 29,059,000

Income from operations 21,783,000 28,176,000

Income tax expense 8,495,000 10,996,000

Net income 13,288,000 17,180,000

Earnings Per Share:

Basic $0.94 $1.24

Diluted $0.93 $1.22

Weighted Shares

Basic 14,091,000 13,889,000

Diluted 14,255,000 14,062,000

CorVel Corporation

Quarterly Results -- Condensed Balance Sheet

March 31, 2007 (audited) and December 31, 2007 (unaudited)

March 31, December 31,

2007 2007

Cash 15,020,000 11,320,000

Accounts receivable, net 41,027,000 40,452,000

Prepaid expenses and taxes 3,090,000 3,508,000

Deferred income taxes 5,150,000 5,139,000

Property, net 24,864,000 30,844,000

Goodwill
'/>"/>

SOURCE CorVel Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. CorVel Corporation Announces Resumption of Stock Repurchases
2. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
3. Naviscan Announces a New Chairman and Board Member
4. Globus Medical Announces Record Revenue for 2007
5. HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires
6. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
7. Sergeants(R) Pet Care Products Announces Cause Marketing Partnership With the National Wildlife Federation
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Mirixa Corporation Announces Leadership Change
10. Medco Announces Date for Fourth-Quarter and Full-Year 2007 Financial Results
11. Finola Hughes Announces Her Best Accessory at Fashion Week
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Over 74 000 Participate in President Obama Teleforum on Healthcare Reform 53015 1Over 74 000 Participate in President Obama Teleforum on Healthcare Reform 53015 2Caraco Pharmaceutical Laboratories Ltd Announces Change to Executive Team as Jitendra N Doshi Assumes Position of CEO 53013 1Caraco Pharmaceutical Laboratories Ltd Announces Change to Executive Team as Jitendra N Doshi Assumes Position of CEO 53013 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 1Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 3